{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T11:00:01Z","timestamp":1786273201976,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics & Gynecology MFM"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ajogmf.2020.100225","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T22:38:43Z","timestamp":1600123123000},"page":"100225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Barriers to accessing opioid agonist therapy in pregnancy"],"prefix":"10.1016","volume":"2","author":[{"given":"Bronwyn S.","family":"Bedrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebony B.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly J.","family":"Stout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie C.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2020.100225_bib2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization United States, 1999\u20132014","volume":"67","author":"Haight","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajogmf.2020.100225_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jsat.2018.04.003","article-title":"Trends and disparities in receipt of pharmacotherapy among pregnant women in publically funded treatment programs for opioid use disorder in the United States","volume":"89","author":"Short","year":"2018","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.ajogmf.2020.100225_bib4","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/1556-4029.12219","article-title":"Prevalence of prescription and illicit drugs in pregnancy-associated non-natural deaths of Florida mothers, 1999\u20132005","volume":"58","author":"Hardt","year":"2013","journal-title":"J\u00a0Forensic Sci"},{"key":"10.1016\/j.ajogmf.2020.100225_bib5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/jp.2015.36","article-title":"Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012","volume":"35","author":"Patrick","year":"2015","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.ajogmf.2020.100225_bib6","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000\u20132009","volume":"307","author":"Patrick","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2020.100225_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jamapediatrics.2019.4791","article-title":"Neonatal abstinence syndrome incidence and health care costs in the United States, 2016","volume":"174","author":"Strahan","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ajogmf.2020.100225_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0889-8545(05)70362-4","article-title":"Opioid dependence during pregnancy. Effects and management","volume":"25","author":"Kaltenbach","year":"1998","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.ajogmf.2020.100225_bib9","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/ALN.0000000000000472","article-title":"Opioid abuse and dependence during pregnancy: temporal trends and obstetrical outcomes","volume":"121","author":"Maeda","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ajogmf.2020.100225_bib10","first-page":"906723","article-title":"Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States","volume":"2014","author":"Whiteman","year":"2014","journal-title":"J\u00a0Pregnancy"},{"key":"10.1016\/j.ajogmf.2020.100225_bib11","unstructured":"An Act to Address Problems Related to Prenatal Opioid Use, Public Law 114-91. 2016. Available at: https:\/\/www.congress.gov\/114\/plaws\/publ91\/PLAW-114publ91.pdf. Accessed December 30, 2019."},{"key":"10.1016\/j.ajogmf.2020.100225_bib12","unstructured":"The Drug Addiction Treatment Act of 2000 (DATA 2000), Public Law 106-310. 2000. Available at: https:\/\/www.congress.gov\/bill\/106th-congress\/house-bill\/2634. Accessed December 30, 2019."},{"key":"10.1016\/j.ajogmf.2020.100225_bib13","unstructured":"Heroin Crisis Act, Illinois Public Act 099-0480. 2015. Available at: http:\/\/www.ilga.gov\/legislation\/publicacts\/99\/099-0480.htm. Accessed December 30, 2019."},{"key":"10.1016\/j.ajogmf.2020.100225_bib14","unstructured":"Comprehensive Addiction and Recovery Act of 2016, Public Law 114-198. 2016. Available at: https:\/\/www.congress.gov\/bill\/114th-congress\/senate-bill\/524\/text. Accessed December 30, 2019."},{"key":"10.1016\/j.ajogmf.2020.100225_bib15","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1377\/hlthaff.2016.0098","article-title":"Access to mental health care increased but not for substance use, while disparities remain","volume":"35","author":"Creedon","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.ajogmf.2020.100225_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.10.015","article-title":"Treatment utilization among persons with opioid use disorder in the United States","volume":"169","author":"Wu","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ajogmf.2020.100225_bib17","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/08897077.2018.1488336","article-title":"Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states","volume":"40","author":"Patrick","year":"2019","journal-title":"Subst Abus"},{"key":"10.1016\/j.ajogmf.2020.100225_bib18","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/AOG.0000000000003231","article-title":"Medication-assisted treatment use among pregnant women with opioid use disorder","volume":"133","author":"Krans","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100225_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2014.07.007","article-title":"Recent trends in treatment admissions for prescription opioid abuse during pregnancy","volume":"48","author":"Martin","year":"2015","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.ajogmf.2020.100225_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/QAI.0000000000000165","article-title":"HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial","volume":"66","author":"Woody","year":"2014","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ajogmf.2020.100225_bib21","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/jama.283.10.1303","article-title":"Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial","volume":"283","author":"Sees","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ajogmf.2020.100225_bib22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ogc.2014.02.005","article-title":"Buprenorphine and methadone for opioid addiction during pregnancy","volume":"41","author":"Mozurkewich","year":"2014","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.ajogmf.2020.100225_bib23","first-page":"CD006318","article-title":"Maintenance agonist treatments for opiate-dependent pregnant women","volume":"12","author":"Minozzi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3 Pt 1","key":"10.1016\/j.ajogmf.2020.100225_bib24","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ajog.2005.03.072","article-title":"High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes","volume":"193","author":"McCarthy","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100225_bib25","first-page":"CD002209","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"2009","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajogmf.2020.100225_bib26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/AOG.0000000000003381","article-title":"National Partnership for Maternal Safety: consensus bundle on obstetric care for women With opioid use disorder","volume":"134","author":"Krans","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2020.100225_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0740-5472(03)00130-2","article-title":"Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS)","volume":"25","author":"Hubbard","year":"2003","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.ajogmf.2020.100225_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11606-006-0258-x","article-title":"Brief report: methadone treatment of injecting opioid users for prevention of HIV infection","volume":"21","author":"Gowing","year":"2006","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.ajogmf.2020.100225_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M18-3457","article-title":"Access to office-based buprenorphine treatment in areas with high rates of opioid-related mortality: an audit study","volume":"171","author":"Beetham","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajogmf.2020.100225_bib31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/add.14436","article-title":"Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder","volume":"114","author":"Jones","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.ajogmf.2020.100225_bib32","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1370\/afm.2384","article-title":"Comparing buprenorphine-prescribing physicians across nonmetropolitan and metropolitan areas in the United States","volume":"17","author":"Lin","year":"2019","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.ajogmf.2020.100225_bib33","article-title":"Access to and payment for office-based buprenorphine treatment in Ohio","volume":"11","author":"Parran","year":"2017","journal-title":"Subst Abus"},{"key":"10.1016\/j.ajogmf.2020.100225_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1370\/afm.1735","article-title":"Geographic and specialty distribution of US physicians trained to treat opioid use disorder","volume":"13","author":"Rosenblatt","year":"2015","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.ajogmf.2020.100225_bib35","first-page":"328","article-title":"Pro. The case for a PDMP in Missouri","volume":"114","author":"Page","year":"2017","journal-title":"Mo Med"},{"issue":"50-51","key":"10.1016\/j.ajogmf.2020.100225_bib36","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths--United States, 2000\u20132014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajogmf.2020.100225_bib38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJMp1107779","article-title":"Taking the mystery out of \u201cmystery shopper\u201d studies","volume":"365","author":"Rhodes","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajogmf.2020.100225_bib39","first-page":"177","article-title":"Opiate-dependent patients on a waiting list\u00a0for methadone maintenance treatment are at high risk for mortality until treatment\u00a0entry","volume":"7","author":"Peles","year":"2013","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.ajogmf.2020.100225_bib40","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/03630242.2012.699508","article-title":"Examining barriers to and motivations for substance abuse treatment among pregnant women: does urban-rural residence matter?","volume":"52","author":"Jackson","year":"2012","journal-title":"Women Health"},{"key":"10.1016\/j.ajogmf.2020.100225_bib41","author":"Morrill"},{"key":"10.1016\/j.ajogmf.2020.100225_bib44","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J\u00a0Biomed Inform"},{"key":"10.1016\/j.ajogmf.2020.100225_bib45","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajogmf.2020.100225_bib48","first-page":"102","article-title":"Assessing differences in the availability of opioid addiction therapy options: rural versus urban and American Indian reservation versus nonreservation","volume":"33","author":"Hirchak","year":"2017","journal-title":"J\u00a0Rural Health"},{"key":"10.1016\/j.ajogmf.2020.100225_bib49","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/08897077.2018.1449166","article-title":"A\u00a0population-based examination of trends\u00a0and disparities in medication treatment for opioid use disorders among Medicaid enrollees","volume":"39","author":"Stein","year":"2018","journal-title":"Subst Abus"},{"key":"10.1016\/j.ajogmf.2020.100225_bib50","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jsat.2010.05.004","article-title":"Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: national surveys of physicians","volume":"39","author":"Arfken","year":"2010","journal-title":"J\u00a0Subst Abuse Treat"}],"container-title":["American Journal of Obstetrics & Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933320301932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933320301932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T23:48:01Z","timestamp":1762904881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933320301932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S2589933320301932"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2020.100225","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Barriers to accessing opioid agonist therapy in pregnancy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2020.100225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100225"}}